Logo image of TBH

BRAG HOUSE HOLDINGS INC (TBH) Stock Fundamental Analysis

NASDAQ:TBH - Nasdaq - US1048132096 - Common Stock - Currency: USD

0.734  +0.02 (+2.09%)

After market: 0.7707 +0.04 (+5%)

Fundamental Rating

0

TBH gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 72 industry peers in the Entertainment industry. TBH may be in some trouble as it scores bad on both profitability and health. TBH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year TBH has reported negative net income.
In the past year TBH has reported a negative cash flow from operations.
TBH Yearly Net Income VS EBIT VS OCF VS FCFTBH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -1M -2M -3M -4M

1.2 Ratios

TBH has a Return On Assets of -252.68%. This is amonst the worse of the industry: TBH underperforms 95.83% of its industry peers.
Industry RankSector Rank
ROA -252.68%
ROE N/A
ROIC N/A
ROA(3y)-476.27%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TBH Yearly ROA, ROE, ROICTBH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 500 -500 1K -1K 1.5K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for TBH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TBH Yearly Profit, Operating, Gross MarginsTBH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -1M -2M -3M

More info and screens

1

2. Health

2.1 Basic Checks

TBH has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for TBH has been reduced compared to a year ago.
TBH Yearly Shares OutstandingTBH Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M 10M
TBH Yearly Total Debt VS Total AssetsTBH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

TBH has an Altman-Z score of -27.79. This is a bad value and indicates that TBH is not financially healthy and even has some risk of bankruptcy.
TBH has a worse Altman-Z score (-27.79) than 90.28% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -27.79
ROIC/WACCN/A
WACCN/A
TBH Yearly LT Debt VS Equity VS FCFTBH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M

2.3 Liquidity

TBH has a Current Ratio of 0.01. This is a bad value and indicates that TBH is not financially healthy enough and could expect problems in meeting its short term obligations.
TBH has a worse Current ratio (0.01) than 95.83% of its industry peers.
A Quick Ratio of 0.01 indicates that TBH may have some problems paying its short term obligations.
With a Quick ratio value of 0.01, TBH is not doing good in the industry: 95.83% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
TBH Yearly Current Assets VS Current LiabilitesTBH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 29.62% over the past year.
Looking at the last year, TBH shows a very negative growth in Revenue. The Revenue has decreased by -99.97% in the last year.
TBH shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -87.64% yearly.
EPS 1Y (TTM)29.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-99.97%
Revenue growth 3Y-87.64%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TBH Yearly Revenue VS EstimatesTBH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 100K 200K 300K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

TBH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TBH Price Earnings VS Forward Price EarningsTBH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TBH Per share dataTBH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

TBH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BRAG HOUSE HOLDINGS INC

NASDAQ:TBH (7/18/2025, 8:14:48 PM)

After market: 0.7707 +0.04 (+5%)

0.734

+0.02 (+2.09%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.34%
Inst Owner Change4.35%
Ins Owners22.04%
Ins Owner Change0%
Market Cap7.94M
AnalystsN/A
Price TargetN/A
Short Float %2.69%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 39709.4
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.31
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS-0.78
TBVpS-0.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -252.68%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-476.27%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z -27.79
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-99.97%
Revenue growth 3Y-87.64%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y24.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.42%
OCF growth 3YN/A
OCF growth 5YN/A